Dual-targeting of mTOR and HSP90 for cancer therapy: Facing oncogenic feed-back-loops and acquired mTOR resistance.

  • Oliver Stöltzing

Bibliographical data

Original languageGerman
Article number11
ISSN1538-4101
Publication statusPublished - 2010
pubmed 20505332